Gain Therapeutics Revenue and Competitors

Lugano,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Gain Therapeutics's estimated annual revenue is currently $6.7M per year.(i)
  • Gain Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Gain Therapeutics has 43 Employees.(i)
  • Gain Therapeutics grew their employee count by 10% last year.

Gain Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Gain Therapeutics?

Gain Therapeutics is a preclinical stage biotech company developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx® technology. The company has several discovery programs in lysosomal storage diseases and CNS indications at various stages of development, all of which validate the platform and offer significant partnering opportunities. Gain Therapeutics was established in 2017 in Lugano by experienced biotech and pharma entrepreneurs.

keywords:N/A

N/A

Total Funding

43

Number of Employees

$6.7M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Gain Therapeutics News

2022-04-19 - How Does Gain Therapeutics Inc (GANX) Stock Rank on Wall Street Wednesday?

InvestorsObserver is giving Gain Therapeutics Inc (GANX) an Analyst Rating Rank of 72, meaning GANX is ranked higher by analysts than 72% of...

2022-04-17 - Gain Therapeutics to Participate in the B. Riley Securities 2022 Virtual Neuro & Ophthalmology Conference

Gain Therapeutics, Inc. is transforming the drug discovery paradigm with structurally targeted allosteric regulators identified with its...

2022-04-06 - Gain Therapeutics Presents Positive Data on its Small ...

BETHESDA, Md., April 12, 2022 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”), a biotechnology company transforming the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.8M5233%N/A
#2
$16M55-8%N/A
#3
N/A607%N/A
#4
N/A6423%N/A
#5
$9M6921%N/A